Petruzzo, PalminaKanitakis, JeanSardu, ClaudiaBassiri-Gharb, BaharMorelon, EmmanuelAmer, HatemBarret, JuanBurt, JamesBrandacher, GeraldGomez, TomasKay, SimonKaminska, DorothaKaufman, Christina LKumar, Dinesh SIglesias, MartinIyer, SubramaniaLandin, LuisLanzetta, MarcoLassus, PatrickLevin, ScottPapay, FrancisPomahac, BohdanSassu, PaoloSatbhai, Nilesh GTalbot, Simon2023-05-032023-05-032022Petruzzo P, Kanitakis J, Sardu C, Bassiri Gharb B, Morelon E, Amer H, et al. VCA in the Era of the COVID-19 Pandemic. Transplantation. 2022 Apr 1;106(4):690-692.http://hdl.handle.net/10668/19870Since its onset in the beginning of 2020, the coronavirus disease 2019 (COVID-19) pandemic has impacted the transplantation community broadly. Indeed, the number of transplantations decreased dramatically and transplantations were temporarily shut down in many localities.1,2 The dramatic impact of the COVID-19 pandemic on solid organ transplant (SOT) recipients began to emerge with reports initially from China, Spain, and Italy. The prevalence of COVID-19 in SOT during the first pandemic wave varied geographically, but despite several reports, the effective incidence of the COVID-19 in SOT recipients remains unclear.2-5 Most relevant, solid organ transplantation (heart, liver, and kidney) rates declined, exposing candidates to an increased rate of waitlist mortality.1enCovid‑19Organ TransplantationSolid Organ TransplantWaiting List MortalityTransplant RecipientsTransplant Activity DeclinePandemic ImpactGeographic VariationHealth Services DisruptionAntigens, ViralCOVID-19Herpesvirus 4, HumanHumansPandemicsresearch article35333847Restricted AccessInfecciones por coronavirusTrasplante de órganosTrasplante de órganos sólidosMortalidad en lista de esperaReceptores de trasplanteReducción de trasplantesImpacto de la pandemia10.1097/TP.00000000000040411534-6080PMC8942593https://journals.lww.com/transplantjournal/Fulltext/2022/04000/VCA_in_the_Era_of_the_COVID_19_Pandemic.5.aspxhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942593/pdf